Home
Dashboard
Curated content
Startups & Scaleups
Corporates
Investors
Funding rounds
Exits
Accelerators
More organizations
Companies
Q32 Bio
Save
Q32 Bio
Developing therapies targeting powerful regulators of innate and adaptive immunity to rebalance the immune system in severe autoimmune and inflammatory diseases.
Overview
Similar companies
Investments (0)
Analytics
Notes
Job openings
Innovations (0)
Recent News about Q32 Bio
Edit